The approval of QUVIVIQ™, a novel dual orexin receptor antagonist, is based on robust clinical efficacy and safety data, including from a Phase 3 trial in Japan that met all primary and secondary ...
Marin Cilic has not played an ATP-level event since February but has been handed a wildcard for the Hangzhou Open - taking ...
Marin Cilic could be set to climb a staggering 405 places in the ATP rankings after excelling in his comeback tournament. The ...
Holger Vitus Nodskov Rune (No. 14) will take on Alejandro Tabilo (No. 22) in the Round of 32 at the Rakuten Japan Open Tennis ...